-
Mashup Score: 3Editorial theme │ Navigating the recent updates to the classification of AML: Validation and refinement of the 2022 ELN classification - 3 month(s) ago
Here, we summarize a study validating and refining the 2022 ELN classification, presented at EHA 2023 by Bill.,1 and a separate study by Rausch et al.,2 published in Leukemia.
Source: aml-hub.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Biomarkers and patient eligibility for CAR T-cell therapies in MM - 7 month(s) ago
During the EHA 2023 Hybrid Congress, the Lymphoma Hub and Multiple Myeloma Hub held a joint satellite session on the ins and outs of CAR T-cells in the real world. Here we share a presentation by Shaji Kumar, Mayo Clinic, Rochester, US, on biomarkers and eligibility for CAR T-cell therapies in multiple myeloma.
Source: multiplemyelomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
At our #EHA2023 symposium, Shaji Kumar @myelomaMD @MayoClinic, discussed: Biomarkers and patient eligibility for CAR T-cell therapies in #multiplemyeloma Watch the presentation, including questions from Ulrich Jäger and the audience. 👉 https://t.co/fsv9L2jhZw #mmsm #CART… https://t.co/h0pCk2nN6O https://t.co/4p09RS5FbF
-
-
Mashup Score: 3Editorial theme | Navigating the recent updates to the classification of AML – the International Consensus Classification - 7 month(s) ago
In the first article of our editorial theme on the latest updates in the classification of AML, we focus on the International Consensus Classification and its key differences from the WHO classification.
Source: aml-hub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Find out about the updated classification of AML from #EHA2023, including key differences between the International Consensus Classification and the 5th edition of the #WHO classification. 👉 https://t.co/512B1vPLq1 #AMLsm #leusm https://t.co/aQ0osxo2MY
-
-
Mashup Score: 3
Share your videos with friends, family, and the world
Source: www.youtube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🔎Gain insight into CAR T-cell therapies across #lymphoma and #multiplemyeloma. Watch the full coverage of our #EHA2023 session, chaired by Ulrich Jäger. The ins and outs of CAR T cells in the real world🌎 👇 https://t.co/iNpE34QTSq #mmsm #lymsm #CART #CARTcells https://t.co/SRIFRLi55I
-
-
Mashup Score: 0Answers to common challenges - 7 month(s) ago
During the European Hematology Association (EHA) 2023 Hybrid Congress, the Lymphoma Hub and Multiple Myeloma Hub held a joint session entitled ‘The ins and o…
Source: www.youtube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
What are the common challenges facing real-world CAR T-cell therapy? At our #EHA2023 session, Michael Hudecek explains the current challenges, the progress that has been made, and answers audience questions. Watch here: https://t.co/E54KIcNw6E #lymsm #mmsm #CART #CARTcells https://t.co/Fiq4XNRvEq
-
-
Mashup Score: 1Real-world patient cases: CAR T-cell therapy - 7 month(s) ago
During the European Hematology Association (EHA) 2023 Hybrid Congress, the Lymphoma Hub and Multiple Myeloma Hub held a joint session entitled ‘The ins and o…
Source: www.youtube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Doris Hansen, Moffitt Cancer Center, Tampa, US, shares a real-world patient case. Watch to learn about the safety and efficacy of CAR T-cell therapy in the real-world setting! 👉 https://t.co/JdYCMgftXA #mmsm #myeloma #CARTtherapy #EHA2023 https://t.co/vfrmTVNTIC
-
-
Mashup Score: 0Welcome and introductions - 7 month(s) ago
During the European Hematology Association (EHA) 2023 Hybrid Congress, the Lymphoma Hub and Multiple Myeloma Hub held a joint session entitled ‘The Ins and o…
Source: www.youtube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🔎Gain insight into CAR T-cell therapies across #lymphoma and #multiplemyeloma. Watch the full coverage of our session at #EHA2023, chaired by Ulrich Jäger. The ins and outs of CAR T cells in the real world🌎 👇 https://t.co/G5PLG6YESO #mmsm #lymsm #CART #CARTcells https://t.co/9rDoubtLVu
-
-
Mashup Score: 1Biomarkers and patient eligibility for CAR T cell therapies in MM - 7 month(s) ago
During the European Hematology Association (EHA) 2023 Hybrid Congress, the Lymphoma Hub and Multiple Myeloma Hub held a joint session entitled ‘The Ins and o…
Source: www.youtube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
At our #EHA2023 symposium, Shaji Kumar @myelomaMD, discussed: Biomarkers and patient eligibility for CAR T-cell therapies in #multiplemyeloma. Watch the presentation, including questions from Ulrich Jäger and the audience. 👉 https://t.co/MddYweilI3 #mmsm #CARTtherapy #myeloma https://t.co/DsMw7aoCfw
-
-
Mashup Score: 0
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Venetoclax plus azacitidine positively impacts health-related quality of life among #elderly patients with #acutemyeloidleukemia compared with azacitidine alone, according to findings from the #EHA2023 Hybrid Congress. https://t.co/dgxRtZSHJl #AML https://t.co/l1iASOKHJJ
-
-
Mashup Score: 1Editorial theme | Navigating the latest updates in classification systems for AML: The 2022 ELN recommendations - 7 month(s) ago
During the EHA 2023, Hartmut Döhner and Gert Ossenkoppele discussed the latest updates to the ELN 2022 recommendations and classification of AML, which we are pleased to summarize below.
Source: aml-hub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
As part of our editorial theme on navigating the latest updates in the classification systems for AML, we summarize two presentations from #EHA2023 discussing the latest updates to the 2022 ELN recommendations & the classification of AML 👉 https://t.co/Cdl3KIARkk. #leusm #AMLsm https://t.co/LN2ibbTycN
-
Check out our latest editorial theme exploring the latest updates in AML classification systems. We summarize a presentation from #EHA2023 and a study by Rausch et al. on the validation and refinement of the 2022 ELN classification. Read here 👉: https://t.co/5Us3D5eGid https://t.co/0kbMVnllJq